The market for Medical Bionic Implants was valued at US$ 25.7 million in 2021, and it is anticipated to increase to US$ 39.5 billion by 2027, with a CAGR of 8.87% during 2022 and 2027.
The market for medical bionic implants is primarily driven by the ageing global population and the accelerating pace of technological innovation. The primary factor driving the market's expansion is the growing preference for bionics over prosthetics due to benefits including faster and better patient recovery. Additionally, it is anticipated that an increase in accidents, organ failures, and age-related conditions such cataracts, hearing loss, arthritis, and cardiovascular illnesses will fuel market expansion. The development of bionic devices like the bio-lung, wearable artificial kidneys, and artificial pancreas by the producers of medical bionic implants is anticipated to further expand the industry. The global market for medical bionic implants is expanding as a result of the rising burden of cardiovascular diseases (CVD). Other factors boosting market expansion include reimbursement regulations for the medical bionic implants industry as well as technological developments for creating better implants. Nonetheless, strict rules for bionic implant approval, significant costs associated with implant manufacturing, and frequent product recalls are projected to limit worldwide market growth. Medical device makers are looking at emerging economies mainly because of their large populations and continued demand for bionic replacements. In addition, a greater number of amputations coupled with improved capabilities of high-tech biomaterial based implants is contributing to the growth of the medical bionic implants market.
Aug. 30, 2021: Zimmer Biomet and Canary Medical Announce FDA De Novo Classification Grant and Authorization to Market the World's First and Only Smart Knee Implant --
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Canary Medical, a medical data company, today announced U.S. Food and Drug Administration (FDA) De Novo classification grant and authorization to market the tibial extension for Persona IQ®, the world's first and only smart knee cleared by the FDA for total knee replacement surgery. Persona IQ combines Zimmer Biomet's proven and trusted knee implant, Persona® The Personalized Knee®, with Canary Medical's proprietary implantable canturioTMte tibial extension sensor technology that measures and determines range of motion, step count, walking speed and other gait metrics.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
North America is the most developed market. This region's high patient awareness levels, strong government R&D initiatives, and demand for technologically sophisticated products are anticipated to positively impact the growth of the medical bionic implant market. The Asia Pacific market is expected to develop at the quickest rate during the forecast period, owing to less rigorous regulations, increased government and corporate investment in the healthcare sector, more knowledge of these implants, and the availability of competent labour forces at affordable prices. The two countries that are rapidly developing in this area are India and China, together with the region's rising patient awareness levels.
The Medical Bionic Implants Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Medical Bionic Implants Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 8.87% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Medtronic, Gambro AB, Boston Scientific, Zimmer Biomet, Asahi Kasei Medical, Roche, Berlin Heart, Baxter International, Thoratec, Abiomed, Jarvik Heart, CONMED Corporation, Wright Medical Group N.V., Stryker, Smith+Nephew, Integra LifeSciences, B. Braun Melsungen AG, Arthrex, Medical Device Business Services, Inc., Globus Medical, DJO, LLC, NuVasive, Inc., Orthopedic Implant Co., Aesculap Inc., Flexicare Medical Limited, BioTek Instruments, Inc., Narang Medical Limited, Auxein Medical, Uteshiya Medicare |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 163 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Medical Bionic Implants Market?
The Medical Bionic Implants Market is growing at a CAGR of 8.87% over the next 5 years.
Who are the key players in Medical Bionic Implants Market?
Medtronic, Gambro AB, Boston Scientific, Zimmer Biomet, Asahi Kasei Medical, Roche, Berlin Heart, Baxter International, Thoratec, Abiomed, Jarvik Heart, CONMED Corporation, Wright Medical Group N.V., Stryker, Smith+Nephew, Integra LifeSciences, B. Braun Melsungen AG, Arthrex, Medical Device Business Services, Inc., Globus Medical, DJO, LLC, NuVasive, Inc., Orthopedic Implant Co., Aesculap Inc., Flexicare Medical Limited, BioTek Instruments, Inc., Narang Medical Limited, Auxein Medical, Uteshiya Medicare
What are the significant types of Medical Bionic Implants Market?
Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs, Others
What are the major end-use applications of Medical Bionic Implants Market?
Hospitals, Clinics, Research Institutes, Others
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.